Targeting immune checkpoint B7-H3 antibody–chlorin e6 bioconjugates for spectroscopic photoacoustic imaging and photodynamic therapy
Chemical Communications2019Vol. 55(95), pp. 14255–14258
Citations Over TimeTop 16% of 2019 papers
Lipeng Zhu, Jie Liu, Guangyu Zhou, Hoi Man Ng, Irene Ang, Guofang Ma, Yubin Liu, Shuo Yang, Fengjuan Zhang, Kai Miao, Terence C. W. Poon, Xuanjun Zhang, Zhen Yuan, Chu‐Xia Deng, Qi Zhao
Abstract
In this study, we constructed bioconjugates of targeting immune checkpoint B7-H3 antibody and chlorin e6 to treat non-small cell lung cancer under the guidance of spectroscopic photoacoustic and fluorescence imaging.
Related Papers
- → Comparison between porphin, chlorin and bacteriochlorin derivatives for photodynamic therapy: Synthesis, photophysical properties, and biological activity(2018)49 cited
- → Monocationic Chlorin as a Promising Photosensitizer for Antitumor and Antimicrobial Photodynamic Therapy(2022)24 cited
- → Thioglycerol-porphyrin, -chlorin, and -phthalocyanine derivatives for photodynamic therapy of UM-UC-3 bladder cancer cells(2023)10 cited
- → Dimeglumin chlorin E6 as a photo-sensitizer in photodynamic therapy in non-oncological diseases(2023)1 cited